About EMBLEEMA INC
Embleema provides a platform for capturing and unifying multimodal patient data for Phase IV and non-interventional research, delivering compliant, complete evidence at 40% lower cost. The platform enables sponsors to generate regulatory-grade real-world data through a customizable solution combining patient and site apps with genomic, clinical, and self-reported data.
Capturing and unifying multimodal patient dataGenerating regulatory-grade real-world dataImplementing protocols using no-code, drag-and-drop modulesProviding audit-ready data capture from day oneEnabling real-time access to datasetsReducing manual data entry with auto-populated eCRFsSupporting decentralized and hybrid study models
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| DEVELOPMENT AND MAINTENANCE OF FDA-ARGOS 2 CONTAINING REGULATORY GRADE REFERENCE GENOMES FOR DIAGNOSTIC USE AN | Department of Health and Human Services | $9.8M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EMBLEEMA INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.